Major interaction on record — check this product against your medications before combining. Based on 2 of 5 ingredients. Check your meds →
Dietary supplement

No Bull Fruit Punch Ingredients & Drug Interactions

by MuscleMeds

Powder Category: Other Combinations
Most serious interaction: Major
The interaction bottom line Most serious interaction: Major

No Bull Fruit Punch is a dietary supplement by MuscleMeds with 5 active ingredients. Its ingredients are commonly taken for replacing fluids and electrolytes, preventing dehydration during exercise or illness, treating low blood sodium (under medical care).Based on those ingredients, 252 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are Sodium, PEAK ATP(R) Patented ATP Molecule. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of No Bull Fruit Punch by MuscleMeds

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 2 of its 5 active ingredients.
  • “NO BULL Peak Performance Matrix” is a proprietary blend — the label gives one combined amount (8,664 mg) without saying how much of each component you get.

No Bull Fruit Punch contains 5 active ingredients. Sodium is the mineral salt that helps with electrolyte balance and hydration.

PEAK ATP (an adenosine-based compound) is designed to support energy production at the cellular level. The product also includes a Power-AMP creatine complex, Uptake Optimizers, and a blend called Sudden Impact Neurotrophic Energizers to support muscle performance and nutrient absorption.

Several inactive ingredients — natural flavors, citric acid, malic acid, silica, acesulfame potassium, sucralose, and Red 40 — are used to flavor and preserve the powder.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use.

Why this rating?
  • The label markets this product for: enhance muscle force velocity and endurance.
  • We looked for evidence on: Athletic performance, muscle strength, muscle endurance, resistance training performance.
  • The closest evidence on file: Adenosine is rated "Insufficient Reliable Evidence To Rate" for Athletic performance (Natural Medicines).

The data on file covers sodium's uses only. Sodium is likely effective for cystic fibrosis and possibly effective for protecting the kidneys from amphotericin B toxicity.

For other claimed benefits — such as heart function or bipolar disorder — the evidence isn't established in the data we hold. We have no effectiveness ratings for the creatine complex, Uptake Optimizers, or Sudden Impact Neurotrophic Energizers, so we can't comment on whether this product works for general muscle performance or energy.

The evidence, ingredient by ingredient Sodium Adenosine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Sodium is well tolerated at normal dietary amounts, but too much is linked to high blood pressure and strain on your heart and kidneys — avoid sodium supplements or very high intake without medical advice. The adenosine in PEAK ATP has limited oral safety data; the prescription injectable form is powerful and used only under medical supervision.

Serious rare effects of excess sodium include worsened cardiovascular disease, high blood pressure, and kidney problems. High sodium intake is also linked to increased risk of gastric cancer in population studies.

Safety data for adenosine supplement use in pregnancy and breastfeeding is not established, so it's best avoided in those situations.

Side effects, ingredient by ingredient Sodium Adenosine

Meds to double-check

Major interaction found
Known Interaction Concern · database check
Major identified

At least one ingredient has a documented Major-severity interaction. Check your medications for a personalized result.

Why this rating?
  • 2 of the 2 matched ingredients can interact with medications — Adenosine, Sodium.
  • The most serious interaction on file is rated Major.
  • Some involve high-stakes drug classes: lithium.
  • For scale: 252 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking this, double-check any of these with your pharmacist: dipyridamole or heart medications, blood pressure drugs, lithium, corticosteroids, carbamazepine, didanosine, sodium phosphate bowel prep, tolvaptan, and any other sodium-containing medications. Also mention if you take methylxanthines (caffeine pills, aminophylline, theophylline).

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with no established evidence rating for its marketed use. Major medication interactions have been identified, and safety information is well characterized.

If you take dipyridamole, lithium, blood pressure medications, corticosteroids, anti-seizure drugs, or any sodium-containing drug, check with your pharmacist before using this product. Avoid it if you're pregnant or breastfeeding until you've talked with your doctor.

Otherwise, use the medication checker on this page to run through your exact prescriptions.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 5 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated May 23, 2014.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about No Bull Fruit Punch, straight from the product label.

Brand MuscleMeds
Barcode (UPC) 891597003884
Net contents 8.11 oz.; 230 Gram(s)
Market status On market
Date entered into DSLD May 23, 2014
DSLD ID 33156
Product type Other Combinations
Supplement form Powder
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for No Bull Fruit Punch by MuscleMeds, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
12 Gram(s)
Maximum serving Sizes:
12 Gram(s)
Servings per container
20
UPC/BARCODE
891597003884
IngredientAmount% DV
Calories5 {Calories}--
Total Carbohydrates1 Gram(s)1%
Sodium10 mg1%
NO BULL Peak Performance Matrix8664 mg--
Power-AMP Cre3-Beta-A Creatine Complex0 NP--
Uptake Optimizers0 NP--
PEAK ATP(R) Patented ATP Molecule400 mg--
Sudden Impact Neurotrophic Energizers0 NP--

Other ingredients: Natural flavors, Citric Acid, Malic Acid, Silica, Acesulfame Potassium, Sucralose, Red 40

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

NO BULL XMT ENHANCES MUSCLE FORCE, VELOCITY, AND ENDURANCE, HELPING YOU TO LIFT HEAVIER WEIGHTS FOR MORE REPS. THE END RESULT IS BIGGER, STRONGER MUSCLES AND BETTER WORKOUTS!

NO BULL XMT (Extreme Muscle Tension) has been formulated with clinically researched ingredients to enhance workout performance and muscle growth through a proven training concept called “Time Under Tension.” During a resistance weight training workout, the amount of time your muscles work is measured in repetitions and the amount of tension is measured in weight. Increasing the numbers of reps (time) and the amount of weight on the bar (tension) during a set increases the workload placed on your muscles and stimulates maximum muscle growth. NO BULL XMT is formulated to do just that. More Reps + More Weight= More Muscle Growth!

PRE-WORKOUT

Claims based on a clinical dose taken before training, based on double-blind placebo controlled study using 400 mg of PEAK ATP, following a specific diet and exercise program. Visit MuscleMedsRX.com for study. Your results may not be typical.

In the development of NO BULL XMT, MuscleMeds researchers focused on a key mechanism in muscle called “Excitation-Contraction.” Enhancing this mechanism of action in muscle tissue helps increase muscle force, velocity and endurance thereby increasing time under tension and total workout performance. In addition to enhancing muscle excitation-contraction, NO BULL XMT’s advanced synergistic design also increases energy, muscle pumps and anabolic signaling, making it the ultimate performance enhancing pre-workout formula. NO BULL XMT is the Pre-Workout Formula for those who want more… More for more reps equals more muscle growth!

PERFORMANCE TECHNOLOGIES GAIN UP TO 8.8 lbs. MUSCLE and 147% MOE STRENGTH LIFT MORE WEIGHT FOR MORE REPS XMT INCREASES MUSCLE FORCE, VELOCITY & ENDURANCE INCREASES BLOOD FLOW & MUSCLE PUMPS INCREASES ANABOLIC SIGNALING TO ACTIVATE MUSCLE GROWTH

Storage

Store at 10(0)-30(0)C (50(0)-86(0)F). Protect from heat, light and moisture.

Precautions

Do not purchase if seal is broken.

Keep out of reach of children

CAUTION: Not intended for use by persons under 18 or if you have high blood pressure, heart problems or are contemplating becoming pregnant. Contains caffeine comparable to a large cup of the leading premium coffee. Caffeine intake is not advisable in cases of high blood pressure, pregnancy or nursing. Limit the use of caffeine-containing medications, foods or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness and occasionally, rapid, heartbeat. If you have a medical condition or are taking medication, consult your physician before using. Do not exceed recommended dose.

CAUTION: Not intended for use by persons under 18 or if you have high blood pressure, heart problems or are contemplating becoming pregnant.

Suggested/Recommended/Usage/Directions

Directions: For full clinical dose, take 1 scoop with 8- 12 fl oz. of water 30 minutes before training

FDA Statement of Identity

Dietary Supplement

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General

MM-003884-0114 F9052301

Formula

Contains caffeine comparable to a large cup of the leading premium coffee.

Naturally Flavored

Seals/Symbols

CLINICALLY PEAK ATP(R) TESTED

Brand IP Statement(s)

BioPerine(R) is a registered trademark of Sabinsa Corp. PEAK ATP(R) is a registered trademark of TSI, Inc. and is used under license.

See for yourself

No Bull Fruit Punch by MuscleMeds label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in No Bull Fruit Punch by MuscleMeds

These are the 5 active ingredients this product is made of. Select any to open its full monograph.

Serving size12 Gram(s) Dosage formPowder Servings per container20 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Sodium

Interacts with
205 drugs
10 mg per serving

Sodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets g...

Sodium monograph & interactions

NO BULL Peak Performance Matrix

8664 mg per serving
  • › Power-AMP Cre3-Beta-A Creatine Complex
  • › Uptake Optimizers
  • › Sudden Impact Neurotrophic Energizers

PEAK ATP(R) Patented ATP Molecule

Interacts with
47 drugs
400 mg per serving

Adenosine is a natural building block your body uses for energy and cell signaling, and a prescription injectable version is used by doctors to treat...

PEAK ATP(R) Patented ATP Molecule monograph & interactions

Other (inactive) ingredients: Natural flavors, Citric Acid, Malic Acid, Silica, Acesulfame Potassium, Sucralose, Red 40. These complete the product’s ingredient list but are not active constituents.

Interaction report

No Bull Fruit Punch by MuscleMeds Drug Interactions

Want to check YOUR meds against No Bull Fruit Punch?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
252Drugs
2 Major 206 Moderate 44 Minor

Ingredients driving the most interactions

Sodium 205

Each ingredient & the kinds of drugs it affects

For each ingredient in No Bull Fruit Punch with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Sodium7 drug types · 205 drugs

Antihypertensive Drugs

Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
High intake of dietary sodium can increase systolic and diastolic blood pressure. Also, high intake of sodium may necessitate increased use of antihypertensive medications to achieve blood pressure control in some patients, such as those with chronic kidney disease.

Likelihood Probable Evidence A
Corticosteroids

Concomitant use of mineralocorticoids and some glucocorticoids with sodium supplements might increase the risk of hypernatremia.
Mineralocorticoids and some glucocorticoids (corticosteroids) cause sodium retention. This effect is dose-related and depends on mineralocorticoid potency. It is most common with hydrocortisone, cortisone, and fludrocortisone, followed by prednisone and prednisolone.

Likelihood Possible Evidence D
Didanosine (Videx)

Concomitant use of didanosine with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia.
Didanosine formulations contain a significant amount of sodium.

Likelihood Probable Evidence C
Lithium

Altering dietary intake of sodium might alter the levels and clinical effects of lithium.
High sodium intake can reduce plasma concentrations of lithium by increasing lithium excretion. Reducing sodium intake can significantly increase plasma concentrations of lithium and cause lithium toxicity in patients being treated with lithium carbonate. Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L. Patients taking lithium should avoid significant alterations in their dietary intake of sodium.

Likelihood Probable Evidence B
Sodium Phosphates

Theoretically, concomitant use of sodium phosphate with sodium supplements might increase the risk of hypernatremia.
Use of high doses (> 45 mL in 24 hours) of sodium phosphate, such as those used for bowel cleansing before surgery, can lead to serious electrolyte disturbances, including hypernatremia. The risk of hypernatremia is highest in the elderly and people with other risk factors for electrolyte disturbances.

Likelihood Possible Evidence D
Sodium-Containing Drugs

Concomitant use of sodium-containing drugs with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia and long-term sodium-related complications.
The Chronic Disease Risk Reduction (CDRR) intake level of 2.3 grams of sodium daily indicates the intake at which it is believed that chronic disease risk increases for the apparently healthy population. Some medications contain high quantities of sodium. When used in conjunction with sodium supplements or high-sodium diets, the CDRR may be exceeded. Additionally, concomitant use may increase the risk for hypernatremia; this risk is highest in the elderly and people with other risk factors for electrolyte disturbances.

Likelihood Possible Evidence D
Tolvaptan (Samsca)

Theoretically, concomitant use of tolvaptan with sodium might increase the risk of hypernatremia.
Tolvaptan is a vasopressin receptor 2 antagonist that is used to increase sodium levels in patients with hyponatremia. Patients taking tolvaptan should use caution with the use of sodium salts such as sodium chloride.

Likelihood Probable Evidence C

PEAK ATP(R) Patented ATP Molecule3 drug types · 47 drugs

Dipyridamole (Persantine)

Dipyridamole can increase the therapeutic and toxic effects of adenosine.
Dipyridamole decreases the metabolism of adenosine. Intravenous infusion of adenosine in patients who are taking dipyridamole can cause dizziness, bradycardia, and syncope. Dipyridamole should be discontinued for several days prior to a cardiac stress test using adenosine.

Likelihood Likely Evidence D
Carbamazepine (Tegretol)

Carbamazepine might increase the risk of heart block when used concomitantly with adenosine.
Carbamazepine and adenosine can both cause heart block. Giving them concurrently might produce an additive effect.

Likelihood Possible Evidence D
Methylxanthines

Methylxanthines are competitive antagonists of adenosine and can block its pharmacologic effects.
The methylxanthines, aminophylline, caffeine, and theophylline, can block the effects of adenosine by acting as competitive antagonists at adenosine cell surface receptors. It is recommended that methylxanthines be avoided for 24 hours prior to cardiac stress tests.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for No Bull Fruit Punch, from the product label.

MuscleMeds

See all MuscleMeds products
Name
MuscleMeds Performance Technologies
Street Address
165 Clinton Road
City
West Caldwell
State
NJ
ZipCode
07006
Phone Number
1.888.575.7067
Web Address
MuscleMedsRx.com
Pharmacist Counseling Corner

No Bull Fruit Punch by MuscleMeds: Common Questions

Does No Bull Fruit Punch by MuscleMeds interact with any medications?
Yes. Based on its ingredients, No Bull Fruit Punch has a known interaction with 252 medications, including 2 rated major. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
No Bull Fruit Punch contains 5 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is the sodium content in this product?
The product facts don't specify the amount of sodium per serving, so check the nutrition label or contact MuscleMeds directly for that detail.
Can I take this if I have high blood pressure?
Not without checking with your doctor or pharmacist first. Sodium may reduce how well blood pressure medications work, and this product's sodium content could work against your treatment.
Is adenosine in this supplement the same as the prescription heart medication?
It's related — PEAK ATP is an adenosine-based ingredient — but the supplement form is different from the powerful injectable prescription drug. Safety data for the oral supplement is limited, so talk to your pharmacist about your individual risk.
Can I take this while breastfeeding?
The data on file advises against using the adenosine ingredient while breastfeeding because safety hasn't been established. Talk with your doctor or pharmacist for personalized advice before starting.
Will this interact with caffeine?
Yes — caffeine and other methylxanthines can block the effects of adenosine in this product. If you take it, avoid caffeine, aminophylline, and theophylline for 24 hours.
Is there evidence this product actually boosts muscle performance?
We don't have effectiveness ratings for most of the ingredients in this blend — the creatine complex, Uptake Optimizers, and the Neurotrophic Energizers aren't covered in our data, so we can't say whether they work for that purpose.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if No Bull Fruit Punch is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

No Bull Fruit Punch label
Sources

Sources & How We Checked

No Bull Fruit Punch's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 48 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Sodium 38 references
  1. Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. Am Fam Physician 1986;33:165-74.
  2. Food and Drug Administration Science Background: Safety of Sodium Phosphates Oral Solution. September 17, 2001. Available at: http://www.fda.gov/cder/drug/safety/sodiumphospate.htm
  3. Coton T, Mallaret C, Coilliot C, Carre D, Guisset M. Severe acute ulcerated gastritis induced by salt. Presse Med 2009;38(3):499-500. PubMed
  4. Frings-Meuthen P, Buehlmeier J, Baecker N, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 2011;111(2):537-542. PubMed
  5. Frings-Meuthen P, Baecker N, Heer M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J Bone Miner Res 2008;23(4):517-524. PubMed
  6. Alam S, Johnson AG. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. J Hum Hypertens 1999;13(6):367-74.
  7. Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2005;18(10):1300-5. PubMed
  8. Bennett WM. Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997;65(2 Suppl):678S-681S. PubMed
  9. Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97(4):383-9. PubMed
  10. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academy Press, 2005. Available at: http://www.nap.edu/openbook.php?record_id=10925. DOI
  11. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31(4):489-98. PubMed
  12. Goldsmith SR. Hyponatremia in heart failure: time for a trial. J Card Fail 2013;19(6):398-400. PubMed
  13. Willocks L, Brettle R, Keen J, Valentine C, Pinching AJ. Formulations of didanosine (ddI) and salt overload. Lancet 1992;339(8786):190.
  14. Chen L, Zhang Z, Chen W, Whelton PK, Appel LJ. Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. Am J Public Health. 2016;106(7):1270-5. PubMed
  15. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981-9. PubMed
  16. Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016;68(15):1609-1617. PubMed
  17. Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465-75. PubMed
  18. Moosavian SP, Haghighatdoost F, Surkan PJ, Azadbakht L. Salt and obesity: a systematic review and meta-analysis of observational studies. Int J Food Sci Nutr. 2017;68(3):265-277. PubMed
  19. O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612-23. DOI
  20. Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695-704. PubMed
  21. Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad
  22. Mahtani KR, Heneghan C, Onakpoya I, et al. Reduced Salt Intake for Heart Failure: A Systematic Review. JAMA Intern Med. 2018 Dec 1;178(12):1693-1700. PubMed
  23. Yancy CW. Sodium Restriction in Heart Failure: Too Much Uncertainty-Do the Trials. JAMA Intern Med. 2018 Dec 1;178(12):1700-1701. PubMed
  24. He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47(6):1784-1795. PubMed
  25. Murthy K, Ondrey GJ, Malkani N, et al. THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2019;25(4):366-378. PubMed
  26. Messerli FH, Hofstetter L, Syrogiannouli L, et al. Sodium intake, life expectancy, and all-cause mortality. Eur Heart J 2021;42(21):2103-2112. PubMed
  27. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2020;12(12):CD004022. PubMed
  28. Giatti S, Santos RB, Aielo AN, et al. Association of sodium with obstructive sleep apnea. The ELSA-Brasil study. Ann Am Thorac Soc 2021;18(3):502-510. PubMed
  29. Nan X, Lu H, Wu J, et al. The interactive association between sodium intake, alcohol consumption and hypertension among elderly in northern China: a cross-sectional study. BMC Geriatr 2021;21(1):135. PubMed
  30. Kyozuka H, Fukusda T, Murata T, et al. Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children's study. Pregnancy Hypertens 2021;23:66-72. PubMed
  31. Zhao L, Ogden CL, Yang Q, et al. Association of usual sodium intake with obesity among US children and adolescents, NHANES 2009-2016. Obesity (Silver Spring) 2021;29(3):587-594. PubMed
  32. Ma Y, He FJ, Sun Q, et al. 24-Hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med 2022;386(3):252-263. PubMed
  33. Liu J, Yang X, Zhang P, et al. Association of urinary sodium excretion and left ventricular hypertrophy in people with type 2 diabetes mellitus: A cross-sectional study. Front Endocrinol (Lausanne) 2021;12:728493. PubMed
  34. Filippini T, Malavolti M, Whelton PK, Vinceti M. Sodium intake and risk of hypertension: A systematic review and dose-response meta-analysis of observational cohort studies. Curr Hypertens Rep 2022;24(5):133-144. PubMed
  35. Wang DD, Li Y, Nguyen XT, et al. Dietary sodium and potassium intake and risk of non-fatal cardiovascular diseases: The million veteran program. Nutrients 2022;14(5):1121. PubMed
  36. Kwak JH, Park CH, Eun CS, et al. The associations of dietary intake of high sodium and low zinc with gastric cancer mortality: A prospective cohort study in Korea. Nutr Cancer 2022;74(10):3501-3508. PubMed
  37. George S, Maiti R, Mishra BR, Jena M, Mohapatra D. Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial. Bipolar Disord 2023;25(1):66-75. PubMed
  38. Zhou TL, Schütten MTJ, Kroon AA, et al. Urinary Sodium Excretion and Salt Intake Are Not Associated With Blood Pressure Variability in a White General Population. J Am Heart Assoc 2023;12(1):e026578. PubMed

See these in context on the Sodium monograph →

Adenosine 10 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 1999;58:211-32.. PubMed
  3. Agteresch HJ, Dagnelie PC, van der Gaast A, et al. Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2000;92:321-8.. PubMed
  4. Haskell CM, Wong M, Williams A, Lee LY. Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer. Med Pediatr Oncol 1996;27:165-73.. DOI
  5. Haskell CM, Mendoza E, Pisters KM, et al. Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest New Drugs 1998;16:81-5.. PubMed
  6. Eisenach JC, Curry R, Hood DD. Dose response of intrathecal adenosine in experimental pain and allodynia. Anesthesiology 2002;97:938-42.. PubMed
  7. Agteresch HJ, Dagnelie PC, Rietveld T, et al. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 2000;56:49-55.. PubMed
  8. Underwood DA. Which medications should be held before a pharmacologic or exercise stress test? Cleve Clin J Med 2002;69:449-50. PubMed
  9. Litmann L, Anderson JD, Monroe MH. Adenosine and Aggrenox: A hazardous combination. Ann Intern Med 2002;137:E-76. PubMed
  10. Faghihi G, Iraji F, Rajaee Harandi M, et al. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenic alopecia and measuring patient satisfaction rate. Acta Dermatovenerol Croat 2013;21(3):155-9.

See these in context on the Adenosine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring